| abstract |
The present invention utilizes the specific ratio of non-racemates of each enantiomer of tramadol, thereby reducing the side effects associated with the administration of racemates (eg, nausea, vomiting, dizziness, constipation, sedation, etc.) and being most effective in terms of effectiveness in analgesic It is based on the finding that therapeutic indices can be achieved. |